Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine

By Seeber A.   Binder M.   Steiner A.   Wolff K.   Pehamberger H.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2129-2131

Elsevier

Access to resources Recommend Favorite

Dacarbazine, Vincristine, Bleomycin and Lomustine plus Natural Interferon-alpha for Metastatic Melanoma

By Reinhold U.   Bruske T.   Kreysel H.W.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 180-180

Elsevier

Access to resources Recommend Favorite

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma

By Kivela T.   Suciu S.   Hansson J.   Kruit W.H.J.   Vuoristo M.-S.   Kloke O.   Gore M.   Hahka-Kemppinen M.   Parvinen L.-M.   Kumpulainen E.   Humblet Y.   Pyrhonen S.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1115-1120

Elsevier

Access to resources Recommend Favorite

Subcutaneous Recombinant Interleukin-2 Plus Chemotherapy with Cisplatin and Dacarbazine in Metastatic Melanoma

By Guida M.   Latorre A.   Mastria A.   De Lena M.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 730-733

Elsevier

Access to resources Recommend Favorite

Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon- after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen

By Atzpodien J.   Lopez Hanninen E.   Kirchner H.   Franzke A.   Korfer A.   Volkenandt M.   Duensing S.   Schomburg A.   Chaitchik S.   Poliwoda H.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 876-881

Elsevier

Access to resources Recommend Favorite